Indefinite Order on Puberty blockers - FAQs

Following the introduction of a UK-wide indefinite order preventing new patients aged under 18, under the care of private prescribers, from being initiated on gonadotrophin-releasing hormone (“GnRH”) analogues (‘puberty blockers’) for the purposes of gender incongruence and/or gender dysphoria, there have been a number of questions and points for clarification about the findings and recommendations of the review and the policy intent of the indefinite order.